«Malignant Carcinoid Syndrome

Below is an extended Malignant Carcinoid Syndrome patents listing. Click here to return to the Malignant Carcinoid Syndrome main in depth entry.

Patents :
US Patent No.	Title
5590656	Application of peptide/cell receptor kinetics utilizing radiolabeled somatostatin congeners in the in situ, in vivo detection and differentiation of neoplastic tissue
5840495	Methods for diagnosis of conditions associated with elevated levels of telomerase activity
5863726	Telomerase activity assays
5869035	Methods and compositions for inducing complement destruction of tissue
5891639	Telomerase activity assays
5985266	Radiation enhanced therapy for tumors expressing a gene for viral thymidine kinase in the presence of a 5-halogengated pyrimidine
5989807	Detecting cancerous conditions by assaying for telomerase activity
6007989	Methods of screening for compounds that derepress or increase telomerase activity
6166178	Telomerase catalytic subunit
6194206	Use of oligonucleotide telomerase inhibitors to reduce telomere length
6342217	Radiation enhanced gene therapy for tumors expressing a gene for a viral pyrimidine kinase in the presence of a 5'-halogenated pyrimidine
5837453	Telomerase activity assays
5830644	Method for screening for agents which increase telomerase activity in a cell
5830431	Radiolabeled peptide compositions for site-specific targeting
5629154	Telomerase activity assays
5639613	Methods for cancer diagnosis and prognosis
5643890	Synthetic oligonucleotides which mimic telomeric sequences for use in treatment of cancer and other diseases
5645986	Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
5648215	Telomerase diagnostic methods
5686245	Methods for screening for agents which modulate telomere length
5693474	Methods for cancer diagnosis and prognosis
5695932	Telomerase activity assays for diagnosing pathogenic infections
5707795	Therapy and diagnosis of conditions related to telomere length and/or telomerase activity
5804380	Telomerase activity assays
6365362	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
6368789	Screening methods to identify inhibitors of telomerase activity
7078491	Selective binding agents of telomerase
7138370	Specific binding agents of human angiopoietin-2
7195911	Mammalian cells that have increased proliferative capacity
7199234	Regulatory segments of the human gene for telomerase reverse transcriptase
7205275	Methods of treatment using specific binding agents of human angiopoietin-2
7232805	Cobalamin conjugates for anti-tumor therapy
7262288	Nucleic acids encoding human telomerase reverse transcriptase and related homologs
7304036	Methods and compositions for the treatment of gastrointestinal disorders
7332288	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
7371727	Methods and compositions for the treatment of gastrointestinal disorders
7041786	Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
7029892	Serine threonine kinase member, h2520-59
6893867	Molecular switch for regulating mammalian gene expression
6391554	Detecting cancerous conditions by assaying for telomerase activity
6475789	Human telomerase catalytic subunit: diagnostic and therapeutic methods
6506559	Genetic inhibition by double-stranded RNA
6534538	Method for slowing heart valve degeneration
6551774	Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity
6610839	Promoter for telomerase reverse transcriptase
6617110	Cells immortalized with telomerase reverse transcriptase for use in drug screening
6645731	Methods and reagents for the rapid and efficient isolation of circulating cancer cells
6660260	Bioprosthetic heart valves
6881542	Serine threonine kinase member, h2520-59
7413864	Treating cancer using a telomerase vaccine

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.